ClinicalThought

Share

Program Content

Activities

  • New Agents for HER2+ MBC
    How I Plan to Use Trastuzumab Deruxtecan and Tucatinib in My Practice
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: January 21, 2020

    Expires: January 19, 2021

  • CNS Mets in HER2+ MBC
    How I Approach CNS Metastases in Patients With HER2-Positive Metastatic Breast Cancer
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 29, 2020

    Expires: April 28, 2021

Provided by

ProCE Banner

Supporters

Daiichi Sankyo, Inc.

Puma Biotechnology, Inc.

Seagen